Table 2

Binding affinities and functional actions of S18327 as compared to other antipsychotic agents

pKipID50
hD1hD2hD3hD4h5-HT1Ah5-HT2Ah5-HT2C1A2AALOCCARACLMDHTWPLOCDSTF
μmol/kg
S183277.27.17.08.17.48.56.49.07.0−0.5−0.30.30.60.6−0.6
Clozapine7.87.16.67.47.08.87.38.96.7−1.4−1.2−0.80.90.7−1.0
Haloperidol8.59.48.58.85.77.15.08.24.70.90.71.40.70.7−0.4
Amperozide6.76.36.45.65.58.25.67.45.9−1.1−1.20.10.00.1−0.3
MDL100,9076.65.54.96.25.09.27.66.65.0−1.4−0.80.71.92.6−0.8
ORG52228.88.98.99.08.410.19.69.28.20.80.61.51.02.20.0
Ocaperidone7.69.28.68.58.010.08.09.77.71.30.61.91.21.60.2
Olanzapine7.98.27.57.65.88.98.17.75.90.003−0.30.61.92.2−1.0
Quetiapine6.76.76.45.66.66.56.28.05.0−1.0−2.0−0.7−0.20.2−1.3
Raclopride5.08.98.85.45.16.75.05.05.00.40.71.30.90.1−0.9
Risperidone7.78.58.08.36.69.47.89.37.60.3−0.12.31.12.3−0.1
Sertindole7.78.68.17.76.410.08.79.96.6−1.3−1.80.4−0.31.6−1.1
Tiospirone7.48.78.68.38.49.38.39.66.70.60.51.20.42.0−0.3
Ziprasidone8.58.37.97.88.99.58.78.96.40.4−0.90.90.41.1−0.9
  • ALOC, amphetamine locomotion; CAR, conditioned avoidance responses; ACLM, apomorphine-induced climbing; DHTW, DOI-induced head-twiches; PLOC, PCP-induced locomotion; DSTF, dizocilpine-induced spontaneous tail-flicks; pID50, log inhibitory dose50and pKi = −log Ki. Data from Millan et al., accompanying paper, 1998a and b and unpublished observations.